BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37696594)

  • 1. Myeloid madness: assessing diagnostic inconsistency between the new WHO and ICC schemes for myelodysplastic/myeloproliferative neoplasms.
    Benton LG; Kallen ME; Jacobs JL; McCool IE; Ning Y; Duong VH; Koka R; Singh ZN
    J Clin Pathol; 2023 Dec; 77(1):68-72. PubMed ID: 37696594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the International Consensus Classification and World Health Organization 5th edition classification to a series of myeloid neoplasms.
    Chopra S; Bailey NG
    Am J Clin Pathol; 2023 Dec; 160(6):566-570. PubMed ID: 37587830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia.
    Falini B; Martelli MP
    Am J Hematol; 2023 Mar; 98(3):481-492. PubMed ID: 36606297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
    Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
    Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissue: Myeloid Neoplasms.
    Loghavi S; Kanagal-Shamanna R; Khoury JD; Medeiros LJ; Naresh KN; Nejati R; Patnaik MM;
    Mod Pathol; 2024 Feb; 37(2):100397. PubMed ID: 38043791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The implications of revised WHO classification (2008) of chronic myeloid neoplasms.
    Găman M; Vlădăreanu AM; Radesi S
    Rom J Intern Med; 2011; 49(1):25-30. PubMed ID: 22026249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coverage and accuracy of myeloproliferative and myelodysplastic neoplasms in the Finnish Cancer Registry.
    Leinonen MK; Rantanen M; Pitkäniemi J; Malila N
    Acta Oncol; 2016 Jun; 55(6):782-6. PubMed ID: 26767306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas.
    Goasguen JE; Bennett JM; Bain BJ; Brunning R; Vallespi MT; Tomonaga M; Zini G; Renault A;
    Br J Haematol; 2018 Aug; 182(4):526-533. PubMed ID: 29917221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular findings in myeloid neoplasms.
    Tran TB; Siddon AJ
    Int J Lab Hematol; 2023 Aug; 45(4):442-448. PubMed ID: 37345257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fifth edition of the World Health Organization Classification and the International Consensus Classification of myeloid neoplasms: evolving guidelines in the molecular era with practical implications.
    Zheng G; Li P; Zhang X; Pan Z
    Curr Opin Hematol; 2023 Mar; 30(2):53-63. PubMed ID: 36728868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A revised 4 edition WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 2017: myeloid neoplasms].
    Kovrigina AM
    Arkh Patol; 2018; 80(6):43-49. PubMed ID: 30585592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of the 5
    Lee C; Kim HN; Kwon JA; Yoon SY; Jeon MJ; Yu ES; Kim DS; Choi CW; Yoon J
    Ann Lab Med; 2023 Sep; 43(5):503-507. PubMed ID: 37080752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelodysplastic/myeloproliferative neoplasms.
    Hyjek E; Vardiman JW
    Semin Diagn Pathol; 2011 Nov; 28(4):283-97. PubMed ID: 22195406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms.
    Gianelli U; Thiele J; Orazi A; Gangat N; Vannucchi AM; Tefferi A; Kvasnicka HM
    Virchows Arch; 2023 Jan; 482(1):53-68. PubMed ID: 36580136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Speaking a common language in MDS/MPNs.
    Steensma DP
    Blood; 2015 Mar; 125(12):1849-51. PubMed ID: 25792730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The International Consensus Classification of myelodysplastic syndromes and related entities.
    Hasserjian RP; Orazi A; Orfao A; Rozman M; Wang SA
    Virchows Arch; 2023 Jan; 482(1):39-51. PubMed ID: 36287260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
    Vardiman JW; Thiele J; Arber DA; Brunning RD; Borowitz MJ; Porwit A; Harris NL; Le Beau MM; Hellström-Lindberg E; Tefferi A; Bloomfield CD
    Blood; 2009 Jul; 114(5):937-51. PubMed ID: 19357394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pay attention to some issues on the diagnostic classification of myelodysplastic syndromes and myeloproliferative neoplasms.].
    Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2010 Apr; 31(4):217-8. PubMed ID: 20510034
    [No Abstract]   [Full Text] [Related]  

  • 20. Myelodysplastic Syndrome Updated.
    Hasserjian RP
    Pathobiology; 2019; 86(1):7-13. PubMed ID: 30041243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.